(Q41601154)

4 October 2017

1 reference

title

Human papillomavirus and other risk factors for cervical cancer (English)

1 reference

Francesc Xavier Bosch José

4 October 2017

author

object named as

Bosch FX

series ordinal

1

0 references

author name string

Muñoz N

series ordinal

2

1 reference

4 October 2017

de Sanjosé S

series ordinal

3

1 reference

4 October 2017

language of work or name

1 reference

1 January 1997

1 reference

Biomedicine and Pharmacotherapy

4 October 2017

published in

1 reference

4 October 2017

volume

51

1 reference

4 October 2017

issue

6-7

1 reference

4 October 2017

page(s)

268-275

1 reference

Estimates of the worldwide incidence of eighteen major cancers in 1985.

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Follow-up of antibody responses to human papillomavirus type 16 E7 in patients treated for cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Can a test for E6/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Cervical cancer and herpes simplex virus type 2: case-control studies in Spain and Colombia, with special reference to immunoglobulin-G sub-classes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Human papillomavirus and invasive cervical cancer in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Risk factors for cervical cancer in Colombia and Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Human papillomavirus—the most significant risk determinant of cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Human papillomavirus testing in primary cervical screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2897%2983542-1

7 January 2021

10.1016/S0753-3322(97)83542-1

Identifiers

DOI

1 reference

4 October 2017

1 reference